Home > Insider Trading > Filing (0001140361-13-004785)

Filing Details

Accession Number:: 0001140361-13-004785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-05 19:08:15
Reporting Period:: 2013-02-01

Filing Date:: 2013-02-05
Accepted Time:: 2013-02-05 19:08:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1023869	Merilee Raines	One Idexx Drive Westbrook ME 04092	Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-01	13,581	$34.37	51,581	No	4	M	Direct
Common Stock	Disposition	2013-02-01	13,581	$94.41	38,000	No	4	S	Direct
Common Stock	Disposition	2013-02-01	31,900	$94.75	6,100	No	4	S	Direct
Common Stock	Disposition	2013-02-01	6,100	$95.86	0	No	4	S	Direct
Common Stock	Disposition	2013-02-01	29,052	$94.74	5,948	No	4	S	Indirect	by Charitable Remainder Trust
Common Stock	Disposition	2013-02-01	5,948	$95.81	0	No	4	S	Indirect	by Charitable Remainder Trust
Common Stock	Acquisiton	2013-02-04	20,440	$41.94	20,440	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	26,000	$28.66	46,440	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	24,000	$25.45	70,440	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	17,736	$56.95	88,176	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	1	$34.37	88,177	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	8,120	$53.31	96,297	No	4	M	Direct
Common Stock	Acquisiton	2013-02-04	2,851	$77.59	99,148	No	4	M	Direct
Common Stock	Disposition	2013-02-04	84,486	$93.63	14,662	No	4	S	Direct
Common Stock	Disposition	2013-02-04	4,862	$94.35	9,800	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	by Charitable Remainder Trust
No	4	S	Indirect	by Charitable Remainder Trust
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-01	13,581	$0.00	13,581	$34.37
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-02-04	2,384	$0.00	2,384	$41.94
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-02-04	3,488	$0.00	3,488	$28.66
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-02-04	3,928	$0.00	3,928	$25.45
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	22,512	$0.00	22,512	$28.66
Commom Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	18,056	$0.00	18,056	$41.94
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	17,736	$0.00	17,736	$56.95
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-02-04	1	$0.00	1	$34.37
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	8,120	$0.00	8,120	$53.31
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	2,851	$0.00	2,851	$77.59
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-02-04	20,072	$0.00	20,072	$25.45

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,144	2016-02-13	No	4	M	Direct
0	2014-02-13	No	4	M	Direct
0	2015-02-02	No	4	M	Direct
0	2014-02-04	No	4	M	Direct
0	2015-02-02	No	4	M	Direct
0	2014-02-13	No	4	M	Direct
2,678	2015-02-13	No	4	M	Direct
2,910	2016-02-13	No	4	M	Direct
10,303	2017-02-13	No	4	M	Direct
10,116	2018-02-13	No	4	M	Direct
0	2014-02-04	No	4	M	Direct

Footnotes

The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $94.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 5, 6 and 7 to this Form 4.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.22 to $95.21, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.22 to $96.18, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $95.23, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.24 to $96.19, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $93.26 to $94.20, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.28 to $94.46, inclusive.
Grant of options to buy shares of common stock becomes exercisable as to 4,527 shares on 02/14/2010, 02/14/2011 and 02/14/2012, 4,526 shares on 02/14/2013, and the remaining 1,618 shares on 02/14/2014.
Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2012) of the grant.
Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/03/2010) of the grant.
Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/05/2009) of the grant.
Grant of options to buy shares of common stock becomes exercisable as to 5,200 shares on 02/03/2006, 02/03/2007, 02/03/2008, and 02/03/2009, and the remaining 1,712 shares on 02/03/2010.
Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, and 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
Grant of options to buy shares of common stock becomes exercisable as to 4,434 shares on 02/14/2009, 02/14/2010, 02/14/2011, and 02/14/2012, and the remaining 2,678 shares on 02/14/2013.
Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
Grant of options to buy shares of common stock becomes exercisable as to 4,060 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 4,059 shares on 02/14/2014, and the remaining 2,184 shares on 02/14/2015.
Grant of options to buy shares of common stock becomes exercisable as to 2,851 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,563 shares on 02/14/2016.
Grant of options to buy shares of common stock becomes exercisable as to 4,800 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 872 shares on 02/05/2009.